Cargando…

Considerations for vaccinating children against COVID-19

COVID-19 vaccines have been introduced in children and adolescents in many countries. However, high levels of community transmission and infection-derived immunity make the decision to introduce COVID-19 vaccination of children in countries yet to do so particularly challenging. For example, other v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hart, John D, Ong, Darren Suryawijaya, Chokephaibulkit, Kulkanya, Ong-Lim, Anna T, Vereti, Ilisapeci, Crawford, Nigel W, Russell, Fiona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373744/ https://www.ncbi.nlm.nih.gov/pubmed/37487674 http://dx.doi.org/10.1136/bmjpo-2023-001964

Ejemplares similares

COVID-19 vaccine boosters in the Asia-Pacific region in the context of Omicron
por: Hart, John D, et al.
Publicado: (2022)

499. Level of Cord Blood Anti-SARs-CoV-2 Antibodies in Infants Born During 2021-2023 to The Mothers Who Had Received COVID-19 Vaccination During Pregnancy
por: Sojisirikul, Nophathai, et al.
Publicado: (2023)

Polyneuritis Cranialis Associated with BNT162b2 mRNA COVID-19 Vaccine in a Healthy Adolescent
por: Kulsirichawaroj, Pimchanok, et al.
Publicado: (2022)

1690. Acute Hematogenous Osteoarticular Infections in Children at Siriraj Hospital, Thailand: A 20-Year Retrospective Review
por: lertamornkitti, nichkamol, et al.
Publicado: (2023)

Immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine as a booster dose in 12- to 18-month-old children primed with 3 doses of 7-valent pneumococcal conjugate vaccine
por: Thisyakorn, Usa, et al.
Publicado: (2014)

Immune Activation and Viral Replication after Vaccination with an Influenza A H1N1 2009 Vaccine in HIV-Infected Children Receiving Antiretroviral Therapy
por: Onlamoon, Nattawat, et al.
Publicado: (2013)

Immunologic hypo- or non-responder in natural dengue virus infection
por: Perng, Guey Chuen, et al.
Publicado: (2013)

Qualitative exploration of intentions, concerns and information needs of vaccine‐hesitant adults initially prioritised to receive COVID‐19 vaccines in Australia
por: Kaufman, Jessica, et al.
Publicado: (2022)

Major considerations in vaccinating children in Africa against COVID-19
por: Osakuade, Oluwanifemi Williams, et al.
Publicado: (2022)

Use of Animal Models in Studying Roles of Antibodies and Their Secretion Cells in Dengue Vaccine Development
por: Chokephaibulkit, Kulkanya, et al.
Publicado: (2020)

Streptococcus pneumoniae Causing Invasive Diseases in Children and Adults in Central Thailand, 2012–2016
por: Phongsamart, Wanatpreeya, et al.
Publicado: (2022)

Evaluation of the Safety and Immunogenicity of Fractional Intradermal COVID-19 Vaccines as a Booster: A Pilot Study
por: Niyomnaitham, Suvimol, et al.
Publicado: (2022)

Immunogenicity and reactogenicity of accelerated regimens of fractional intradermal COVID-19 vaccinations
por: Niyomnaitham, Suvimol, et al.
Publicado: (2023)

Immunogenicity and Safety of an MF59-adjuvanted Quadrivalent Seasonal Influenza Vaccine in Young Children at High Risk of Influenza-associated Complications: A Phase III, Randomized, Observer-blind, Multicenter Clinical Trial
por: Esposito, Susanna, et al.
Publicado: (2020)

Zika Virus Disease Comparing Children and Adults in a Dengue-Endemic Setting
por: Wongsawat, Jurai, et al.
Publicado: (2021)

Serial head circumference measurements should be used to classify congenital microcephaly
por: Sengasai, Chutima, et al.
Publicado: (2023)

Factors Influencing Australian Healthcare Workers’ COVID-19 Vaccine Intentions across Settings: A Cross-Sectional Survey
por: Kaufman, Jessica, et al.
Publicado: (2021)

Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand
por: Mahasing, Chayanit, et al.
Publicado: (2023)

A cost-effectiveness analysis of the 13-valent pneumococcal conjugated vaccine and the 23-valent pneumococcal polysaccharide vaccine among Thai older adult
por: Ngamprasertchai, Thundon, et al.
Publicado: (2023)

Factors impacting COVID-19 vaccine decision making in older adults and people with underlying conditions in Victoria, Australia: A cross-sectional survey
por: Biezen, Ruby, et al.
Publicado: (2022)

Correction: Mahasing et al. Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand. Vaccines 2023, 11, 749
por: Mahasing, Chayanit, et al.
Publicado: (2023)

Outcomes of Single-Dose Empirical Antibiotic Treatment in Children With Suspected Sepsis Implemented in the Emergency Department
por: Khanthathasiri, Suwimon, et al.
Publicado: (2022)

Persistence of hepatitis B immune memory until 9–10 years of age following hepatitis B vaccination at birth and DTaP-IPV-HB-PRP∼T vaccination at 2, 4 and 6 months
por: Kosalaraksa, Pope, et al.
Publicado: (2018)

Health-related Quality of Life of Thai children with HIV infection: a comparison of the Thai Quality of Life in Children (ThQLC) with the Pediatric Quality of Life Inventory™ version 4.0 (PedsQL™ 4.0) Generic Core Scales
por: Punpanich, Warunee, et al.
Publicado: (2010)

A Normal Reference of Bone Mineral Density (BMD) Measured by Dual Energy X-Ray Absorptiometry in Healthy Thai Children and Adolescents Aged 5–18 Years: A New Reference for Southeast Asian Populations
por: Nakavachara, Pairunyar, et al.
Publicado: (2014)

HIV seronegativity in children, adolescents and young adults living with perinatally acquired HIV: A cross‐sectional study in Thailand
por: Wirotpaisankul, Praew, et al.
Publicado: (2020)

Case Report: Reemerging Paragonimiasis in Umphang District, Thailand
por: Hanprom, Jiranat, et al.
Publicado: (2023)

Immunological considerations for COVID-19 vaccine strategies
por: Jeyanathan, Mangalakumari, et al.
Publicado: (2020)

Immunogenicity of a single dose of BNT162b2, ChAdOx1 nCoV-19, or CoronaVac against SARS-CoV-2 delta and omicron variants among previously infected adults: A randomized trial
por: Niyomnaitham, Suvimol, et al.
Publicado: (2022)

Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults
por: Niyomnaitham, Suvimol, et al.
Publicado: (2022)

Immunogenicity and reactogenicity of heterologous COVID-19 vaccination in pregnant women
por: Chayachinda, Chenchit, et al.
Publicado: (2023)

Cells in Dengue Virus Infection In Vivo
por: Noisakran, Sansanee, et al.
Publicado: (2010)

A phase 3 study of safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine, in children with HIV
por: Wilck, Marissa, et al.
Publicado: (2023)

Considerations on COVID-19 vaccination
por: La Cava, Antonio
Publicado: (2023)

Effectiveness of bivalent mRNA booster vaccines against COVID-19: methodological and public health considerations
por: Stoliaroff-Pepin, Anna, et al.
Publicado: (2023)

Disparities in parental awareness of children’s seasonal influenza vaccination recommendations and influencers of vaccination
por: Tuckerman, Jane, et al.
Publicado: (2020)

Safety and immunogenicity of intradermal administration of fractional dose CoronaVac(®), ChAdOx1 nCoV-19 and BNT162b2 as primary series vaccination
por: Chatsiricharoenkul, Somruedee, et al.
Publicado: (2022)

Early treatment of Favipiravir in COVID-19 patients without pneumonia: a multicentre, open-labelled, randomized control study
por: Sirijatuphat, Rujipas, et al.
Publicado: (2022)

Serological Response of Patients with Influenza A (H1N1) pdm09-Associated Pneumonia: An Observational Study
por: Angkasekwinai, Nasikarn, et al.
Publicado: (2013)

Amino acid substitutions in hemagglutinin of the 2009 pandemic influenza A(H1N1) viruses that might affect the viral antigenicity
por: Kosoltanapiwat, Nathamon, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2du53n5nc81lr42qmqdmfmll2k